ROCHESTER, Minn. -- Pancreatic cancer kills 30,000 Americans every year. Not only is there no cure, but there are no effective treatments. That may change if a new finding by Mayo Clinic researchers continues to show promise. In the March 15 issue of the journal Cancer Research, (http://cancerres.aacrjournals.org/future/65.6.shtml
) investigators describe discovering a key molecule that controls the growth, spread and survival of pancreatic cancer cells. This is a critical first step toward developing new and better treatments for patients with pancreatic cancer.
"This is a very exciting -- and surprising -- finding," says Daniel Billadeau, Ph.D., lead author of the report. To identify new target molecules with potentially therapeutic impact for a cancer for which there is currently no real useful treatment is incredibly important.
"Based on the literature, you would predict the opposite of what we found. But in fact, we determined that we can decrease a known regulator of cancer cell survival -- in effect, turn this regulator off -- and when we do, the pancreatic cancer cells undergo apoptosis (commit cell suicide) and die."
Significance of the Research
With this finding, a new path is cleared for researchers to target these key molecular players with new small molecule inhibitors to block their action, effectively turning off molecules that promote pancreatic cancer growth.
The finding may be applied to make pancreatic cells more sensitive to gemcitabine, the sole drug available for treating pancreatic cancer.
This discovery may lead to new drug development strategies for other cancers. Additional research will tell whether these same actors play a similar role in the spread of other cancer types.
The Key Finding
The Mayo Clinic researchers discovered a previously unrecognized role in pancreatic cancer for
Contact: Bob Nellis
Mayo Clinic 15-Mar-2005Page: 1 2 Related medicine news :1
. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm2
. Mayo Clinic study sets threshold for valve repair surgery3
. Mayo Clinic researcher calls for improved newborn screening4
. Mayo Clinic study finds obese kidney donors face few increased risks5
. Mayo Clinic identifies key cellular process in prostate and other cancers6
. Clinical breast examination offers modest benefit to breast cancer screening program7
. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer8
. Clinicians report missing patient information is common9
. Mayo Clinic discovers a key to low metabolism and major factor in obesity10
. Clinical trial of Etanercept for Wegeners disease shows no benefit11
. Mayo Clinic researchers identify new form of muscular dystrophy in adults